NASDAQ: CV
Capsovision Inc Stock

$4.61+0.42 (+10.02%)
Updated Jul 8, 2025
CV Price
$4.61
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$3.49
52 Week High
$5.72
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-0.03
Operating Cash Flow
N/A
Beta
18.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CV Overview

Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CV's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
CV
Ranked
#65 of 105

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$12.33A
$29.77A
$232.57A
View Top Medical Device Stocks

Be the first to know about important CV news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CV's short-term assets ($10.59M) exceed its short-term liabilities ($2.73M)
Short-term Liabilities Financials
CV's short-term assets ($10.59M) exceed its long-term liabilities ($788.00k)
Long-term Liabilities Financials
CV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more CV due diligence checks available for Premium users.

Valuation

CV's financial health

Profit margin

Revenue
$2.8M
Net Income
-$5.4M
Profit Margin
-193.1%

Assets to liabilities

Assets
$12.4M
Liabilities
$3.5M
Debt to equity
-0.03
CV's short-term assets ($10.59M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CV's short-term assets ($10.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.0M
Investing
-$40.0k
Financing
$34.0k

CV vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AIMD$12.83M-6.36%-0.48x0.98x
ALGNC$14.17B+0.85%35.54x3.73x
APYX$89.57M-8.14%-4.31x8.52x
AXGNC$522.85M+1.06%-76.53x4.96x
ADGM$26.92M+6.06%-0.14x2.17x

Capsovision Stock FAQ

What is Capsovision's quote symbol?

(NASDAQ: CV) Capsovision trades on the NASDAQ under the ticker symbol CV. Capsovision stock quotes can also be displayed as NASDAQ: CV.

If you're new to stock investing, here's how to buy Capsovision stock.

What is the 52 week high and low for Capsovision (NASDAQ: CV)?

(NASDAQ: CV) Capsovision's 52-week high was $5.72, and its 52-week low was $3.49. It is currently -19.41% from its 52-week high and 32.09% from its 52-week low.

How much is Capsovision's stock price per share?

(NASDAQ: CV) Capsovision stock price per share is $4.61 today (as of Jul 8, 2025).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.